AstraZeneca PLC Stock Price and Value Analysis

Should you buy AstraZeneca PLC stock? (NYSE:AZN). Let's see how it does in our automated value investing analysis system.

AZN Free Cash Flow Trend

Free Cash Flow trendline for AZN
Free Cash Flow trendline for AstraZeneca PLC

Hmm, we can't give any reliable projection for AstraZeneca PLC's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has a large dividend yield!
  • This company has fluctuating growth.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.

Inside the AZN Numbers

AZN Price
(AstraZeneca PLC stock price per share)
[?] PE Ratio versus Sector 157% higher than other Healthcare stocks
[?] PE Ratio versus Industry 202% higher than other Drug Manufacturers - Major stocks
[?] Cash Yield 2.91%
[?] Free Cash Flow Jitter 28%
[?] Dividend Yield 3%

Is AstraZeneca PLC Stock on Sale?

Based on our analysis, we believe that you should not buy AstraZeneca PLC right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy AZN Stock?

Does AstraZeneca PLC have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.